Seegene Inc
KOSDAQ:096530
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Seegene Inc
KOSDAQ:096530
|
KR |
|
Apex Resources Inc
XTSX:APX
|
CA |
|
E
|
Ecograf Ltd
F:FMK
|
AU |
|
Palace Capital PLC
LSE:PCA
|
UK |
|
Tiong Seng Holdings Ltd
SGX:BFI
|
SG |
Intrinsic Value
Is Seegene Inc undervalued or overvalued?
See the intrinsic value estimate for Seegene Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Seegene Inc looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with Seegene Inc’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Seegene Does
Seegene Inc. makes molecular diagnostic tests used to detect infectious diseases and other medical conditions from patient samples. Its core products are test kits, instruments, and software that labs use to run PCR-based testing and interpret results. The company focuses on the technology that lets one sample be tested for many targets at once, which helps laboratories identify the exact cause of an infection more quickly and efficiently.
- Headquarters
- Korea KR
- Employees
- 1 008
- IPO date
- Sep 10, 2010
Revenue & Expenses Breakdown
Seegene Inc
Earnings Waterfall
Seegene Inc
The intrinsic value for Seegene Inc (096530) under the Base Case is hidden KRW.
Compared with the current market price of 33 850 KRW, the stock appears hidden.